SANARA MEDTECH INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$28M
↑+4.7% +$1Mvs FY2024 (Q4)
Gross Profit
$26M
↑+6.7% +$2Mvs FY2024 (Q4)
Operating Income
$1M
↑+118.7% +$570Kvs FY2024 (Q4)
Net Income
$702K
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $28M | $26M |
| COGS | $2M | $2M |
| Gross Profit | $26M | $24M |
| R&D | $2M | $0 |
| SG&A | $20M | $18M |
| D&A | $668K | $2M |
| Other OpEx | $2M | $4M |
| Operating Income | $1M | $480K |
| Interest Exp. | $349K | $480K |
| Other Non-Op | $0 | $0 |
| Pretax Income | $702K | $0 |
| Tax | $0 | $0 |
| Net Income | $702K | $0 |
QuarterCharts · SEC EDGAR data · SMTI · Comparing FY2025 (Q4) vs FY2024 (Q4)